Astrana HealthASTH +3.09%87 Forward PE Ratio is 37.31 as of Jun. 30, 2026. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 312 Healthcare Providers & Services companies, Astrana Health ranks worse than 78.85% on this metric.
Astrana Health (NAS:ASTH) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Astrana Health Forward PE Ratio Related Terms
Astrana Health Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Astrana Health's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astrana Health Forward PE Ratio Chart
Astrana Health Annual Data
Trend
2025-12
Forward PE Ratio
20.33
Astrana Health Quarterly Data
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
18.51
14.98
13.07
20.33
19.59
ASTH vs SGRY, SEM, MD: Forward PE Ratio Comparison
For the Medical Care Facilities subindustry, Astrana Health's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Astrana Health's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Astrana Health (ASTH) has a Forward PE Ratio of 37.31 as of Jun. 30, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Astrana Health and its competitors. According to the industry distribution chart, Astrana Health ranks #246 out of 312 companies in the Healthcare Providers & Services industry, placing it in the top 78.8%.
Is Astrana Health's Forward PE Ratio too high?
Astrana Health's current Forward PE Ratio is 37.31. The Healthcare Providers & Services industry median Forward PE Ratio is 18.13. Astrana Health's value of 37.31 is 105.8% above this industry median. Based on the distribution chart, Astrana Health ranks #246 out of 312 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Forward PE Ratio compare to SGRY and SEM?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #246 out of 312 companies for Forward PE Ratio. This places Astrana Health in the lower half of its industry. The industry median Forward PE Ratio is 18.13. Astrana Health's value of 37.31 is 105.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 18.13, based on 312 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current Forward PE Ratio of 37.31 is 105.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 18.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current Forward PE Ratio is 37.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $46.41 — trading 43.6% below its estimated fair value. The current Forward PE Ratio is 37.31 and 105.8% above the Healthcare Providers & Services industry median of 18.13. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Astrana Health (ASTH), the current Forward PE Ratio is 37.31 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (ASTH) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of $46.41 is trading 43.6% below its estimated GF Value™ of $82.34.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for ASTH:
Forward PE Ratio: 37.31
GF Value™: $82.34 vs. price of $46.41 (43.6% below fair value)
Industry Position: 105.8% above the Healthcare Providers & Services median (#246 of 312)
No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score
Get the complete analysis for ASTH
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASTH has been successfully added to your 